Shanghai copper fell more than 3 per cent in early trade on Wednesday, tracking London prices which the session before saw their biggest drop since July 2015. The most-traded Shanghai Futures Exchange copper contract was down 3.2 per cent at 51,350 yuan a ... ( read original story ...)
Canadians doing business in China should be warned of possible trouble, former envoy says
A former Canadian ambassador to China says Ottawa should issue a prominent and official warning to Canadian business people that commercial ... says the case of two Canadian wine merchants held captive in Shanghai is a troubling sign of a bigger problem. ( read original story ...)
Former envoy David Mulroney says official warning needed for Canadians doing business in China
A former Canadian ambassador to China says Ottawa should issue a prominent and official warning to Canadian business people that commercial ... says the case of two Canadian wine merchants held captive in Shanghai is a troubling sign of a bigger problem. ( read original story ...)
Why companies are turning away from offices in Shanghai’s main business areas
A growing number of companies in Shanghai are considering relocating to offices away from the central business areas, where they can pay up to 40 per cent less in rent. The city’s “non-CBD” office market is booming as firms increasingly choose to ... ( read original story ...)
Wanxiang Blockchain Releases Blockchain and Distributed Business White Paper
SHANGHAI, Nov. 22, 2017 /PRNewswire/ Technology has been continuously pushing the evolution of business forms since the primitive age and it still does in the Internet era, which is, in essence, technology reshapes business logic. With the development of ... ( read original story ...)
Shanghai Pharma expands reach
... Holding Co at an exhibition of pharmaceutical and medical products held in Shanghai. The company is buying Cardinal Health Inc's drug distribution business in China.JING WEI/FOR CHINA DAILY Chinese firm buys drug distribution unit of US-based Cardinal ... ( read original story ...)
Shanghai Pharma to buy Cardinal Health’s China business for $557m
Chinese state-owned drugmaker Shanghai Pharmaceuticals said on Wednesday it had agreed to pay for $557m for Cardinal Health Inc’s China business, one of the country’s largest drug distributors. Shanghai Pharmaceuticals said in a statement that the ... ( read original story ...)